DSpace Repository

Synthesis, molecular docking, and QSAR study of bis-sulfonamide derivatives as potential aromatase inhibitors

Show simple item record

dc.contributor.author Leechaisit R.
dc.contributor.author Pingaew R.
dc.contributor.author Prachayasittikul V.
dc.contributor.author Worachartcheewan A.
dc.contributor.author Prachayasittikul S.
dc.contributor.author Ruchirawat S.
dc.contributor.author Prachayasittikul V.
dc.date.accessioned 2021-04-05T03:02:35Z
dc.date.available 2021-04-05T03:02:35Z
dc.date.issued 2019
dc.identifier.issn 9680896
dc.identifier.other 2-s2.0-85070395327
dc.identifier.uri https://ir.swu.ac.th/jspui/handle/123456789/12289
dc.identifier.uri https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070395327&doi=10.1016%2fj.bmc.2019.08.001&partnerID=40&md5=6bf733408e7c36b895365a553545d17e
dc.description.abstract A library of bis-sulfonamides (9–26) were synthesized and tested for their aromatase inhibitory activities. Interestingly, all bis-sulfonamide derivatives inhibited the aromatase with IC50 range of 0.05–11.6 μM except for compound 23. The analogs 15 and 16 bearing hydrophobic chloro and bromo groups exhibited the potent aromatase inhibitory activity in sub-micromolar IC50 values (i.e., 50 and 60 nM, respectively) with high safety index. Molecular docking revealed that the chloro and bromo benzenesulfonamides (15 and 16) may play role in the hydrophobic interaction with Leu477 of the aromatase to mimic steroidal backbone of the natural substrate, androstenedione. QSAR study also revealed that the most potent activity of compounds was governed by van der Waals volume (GATS6v) and mass (Mor03m) descriptors. Finally, the two compounds (15 and 16) were highlighted as promising compounds to be further developed as novel aromatase inhibitors. © 2019 Elsevier Ltd
dc.subject androstenedione
dc.subject aromatase
dc.subject benzenesulfonamide derivative
dc.subject doxorubicin
dc.subject letrozole
dc.subject n,n' (1,3 phenylene)bis(4 chlorobenzenesulfonamide)
dc.subject n,n' (1,3 phenylene)bis(4 methoxybenzenesulfonamide)
dc.subject n,n' [1,3 phenylenebis(methylene)]bis(2 nitrobenzenesulfonamide)
dc.subject n,n' [1,3 phenylenebis(methylene)]bis(2,3,5,6 tetramethylbenzenesulfonamide)
dc.subject n,n' [1,3 phenylenebis(methylene)]bis(3 aminobenzenesulfonamide)
dc.subject n,n' [1,3 phenylenebis(methylene)]bis(3 nitrobenzenesulfonamide)
dc.subject n,n' [1,3 phenylenebis(methylene)]bis(4 acetylbenzenesulfonamide)
dc.subject n,n' [1,3 phenylenebis(methylene)]bis(4 bromobenzenesulfonamide)
dc.subject n,n' [1,3 phenylenebis(methylene)]bis(4 chlorobenzenesulfonamide)
dc.subject n,n' [1,3 phenylenebis(methylene)]bis(4 cyanobenzenesulfonamide)
dc.subject n,n' [1,3 phenylenebis(methylene)]bis(4 fluorobenzenesulfonamide)
dc.subject n,n' [1,3 phenylenebis(methylene)]bis(4 methoxybenzenesulfonamide)
dc.subject n,n' [1,3 phenylenebis(methylene)]bis(4 methylbenzenesulfonamide)
dc.subject n,n' [1,3 phenylenebis(methylene)]bis(4 nitrobenzenesulfonamide)
dc.subject n,n' [1,3 phenylenebis(methylene)]bis(4 trifluoromethylbenzenesulfonamide)
dc.subject n,n' [1,3 phenylenebis(methylene)]bis(naphthalene 2 sulfonamide)
dc.subject n,n' [1,4 phenylenebis(methylene)]bis(2,3,5,6 tetramethylbenzenesulfonamide)
dc.subject n,n' [1,4 phenylenebis(methylene)]bis(4 cyanobenzenesulfonamide)
dc.subject sulfonamide
dc.subject unclassified drug
dc.subject aromatase
dc.subject aromatase inhibitor
dc.subject protein binding
dc.subject sulfonamide
dc.subject Article
dc.subject breast cancer
dc.subject controlled study
dc.subject drug cytotoxicity
dc.subject drug potency
dc.subject drug safety
dc.subject drug structure
dc.subject drug synthesis
dc.subject enzyme inhibition
dc.subject hydrophobicity
dc.subject IC50
dc.subject molecular docking
dc.subject MRC-5 cell line
dc.subject quantitative structure activity relation
dc.subject structure activity relation
dc.subject T-47D cell line
dc.subject binding site
dc.subject chemical structure
dc.subject chemistry
dc.subject human
dc.subject metabolism
dc.subject molecular library
dc.subject pharmacology
dc.subject synthesis
dc.subject tumor cell line
dc.subject Aromatase
dc.subject Aromatase Inhibitors
dc.subject Binding Sites
dc.subject Cell Line, Tumor
dc.subject Humans
dc.subject Molecular Docking Simulation
dc.subject Molecular Structure
dc.subject Protein Binding
dc.subject Quantitative Structure-Activity Relationship
dc.subject Small Molecule Libraries
dc.subject Sulfonamides
dc.title Synthesis, molecular docking, and QSAR study of bis-sulfonamide derivatives as potential aromatase inhibitors
dc.type Article
dc.rights.holder Scopus
dc.identifier.bibliograpycitation Bioorganic and Medicinal Chemistry. Vol 27, No.19 (2019)
dc.identifier.doi 10.1016/j.bmc.2019.08.001


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics